Literature DB >> 28350047

Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer.

Chiara Tuccilli1, Enke Baldini2, Yannick Arlot-Bonnemains3, Frank Chesnel3, Salvatore Sorrenti2, Corrado De Vito4, Eleonora D'Armiento1, Alessandro Antonelli5, Poupak Fallahi5, Sara Watutantrige6, Francesco Tartaglia2, Susi Barollo6, Caterina Mian6, Stefano Arcieri2, Domenico Mascagni2, Daniele Pironi2, Marco Bononi7, Massimo Vergine2, Massimo Monti2, Angelo Filippini2, Salvatore Ulisse2.   

Abstract

Establishment and maintenance of the apical-basal cell polarity, required for proper replication, migration, specialized functions and tissue morphogenesis, relies on three evolutionary conserved complexes: PAR, CRUMBS and SCRIBBLE. Loss of cell polarity/cohesiveness (LOP/C) is implicated in cancer progression, and members of the polarity complex have been described as either oncogenes or oncosuppressors. However, no information on their role in thyroid cancer (TC) progression is available. In the present study, we evaluated the gene expression of the PAR complex members aPKCι, PARD3α/β and PARD6α/β/γ in 95 papillary TC (PTC), compared to their normal matched tissues and in 12 anaplastic TC (ATC). The mRNA and protein levels of investigated genes were altered in the majority of PTC and ATC tissues. In PTC, univariate analysis showed that reduced expression of aPKCι, PARD3β and PARD6γ mRNAs is associated with increased tumor size, and the reduced expression of PARD3β mRNA is associated also with recurrences. Multivariate analysis demonstrated that the presence of lymph node metastasis at diagnosis and the reduced expression of PARD3β are independent risk factors for recurrences, with hazard ratio, respectively, of 8.21 (p=0.006) and 3.04 (p=0.029). The latter result was confirmed by the Kaplan-Meier analysis, which evidenced the association between decreased PARD3β mRNA levels and shorter disease-free interval. In conclusion, we demonstrated that the expression of PAR complex components is deregulated in the majority of PTC and there is a general trend towards their reduction in ATC tissues. Moreover, a prognostic value for the PARD3β gene in PTCs is suggested.

Entities:  

Year:  2017        PMID: 28350047     DOI: 10.3892/ijo.2017.3907

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

1.  Incidental thyroid carcinomas. A retrospective study.

Authors:  A Maturo; L Tromba; L De Anna; G Carbotta; G Livadoti; C Donello; F Falbo; G Galiffa; Antonella Esposito; A Biancucci; S Carbotta
Journal:  G Chir       Date:  2017 Mar-Apr

2.  CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers.

Authors:  Chiara Tuccilli; Enke Baldini; Salvatore Sorrenti; Antonio Catania; Alessandro Antonelli; Poupak Fallahi; Francesco Tartaglia; Susi Barollo; Caterina Mian; Andrea Palmieri; Giovanni Carbotta; Stefano Arcieri; Daniele Pironi; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Int J Endocrinol       Date:  2018-07-05       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.